The Relationship Between Nodal Metastases and Primary Location in Stage I Non-Small Cell Lung Cancer

被引:0
|
作者
Wagner, Grant [1 ]
Xie, Rongbing [2 ]
Donahue, James [2 ,3 ]
Wei, Benjamin [1 ,2 ,3 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Zeigler Res Bldg 707,703 19 th St South, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Surg, Div Cardiothorac Surg, Birmingham, AL USA
[3] Birmingham VA Hlth Care Ctr, Birmingham, AL USA
关键词
Lung cancer location; Lymph node sampling; Metastasis; Nodal upstaging; Non-small cell lung cancer; Predictors; PREDICTOR;
D O I
10.1016/j.jss.2024.07.102
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: This study examines the relationship between location of the primary tumor and specific nodal metastases in clinical stage 1 non-small cell lung cancer (NSCLC) patients undergoing lobectomy. Methods: We retrospectively analyzed all lobectomies performed at a single institution, between January 2005 and December 2019, for clinical stage I NSCLC patients. Patients selected for this study were clinically node negative (cN0) by positron emission tomography-computed tomography scan and selectively by endobronchial ultrasound or mediastinoscopy. Cases of postoperative pathologic nodal upstaging were identified among these patients. For each patient upstaged, the specific lymph node stations found to be positive were recorded. Descriptive statistics, chi-squared tests, and Fisher's exact test were utilized to identify independent risk factors for upstaging to specific N1 and N2 lymph node stations. All clinical and pathologic staging information was retrospectively normalized to the International Association for the Study of Lung Cancer 8th Edition TNM Classification. Results: The research cohort included 645 patients. The mean age was 68 years (standard deviation f 9.2), 54% were female, and 88% were White, 11% Black, and 1% other. Twelve percent (n = 75) were upstaged from cN0 to pN1 or pN2 upon final pathologic examination: 41 to pN1 (54.7%) and 34 to pN2 (45.3%). The primary tumor location with the highest rate of nodal upstaging was the left upper lobe (LUL) (12.8%). Tumors in the right middle lobe had the lowest rate of unsuspected nodal metastases (8.8%). Out of all upstaged patients, there were no positive level eight lymph nodes, and only 1 patient with a positive level nine lymph node. Lymph node levels five and six were only positive in LUL primary tumors, a relationship that approached statistical significance (P = 0.0797). No patients with a LUL primary tumor had a positive level seven lymph node. Upstaging at station 12 was significantly associated with the location of the primary tumor, occurring less often in tumors originating in the right upper lobe in comparison to other lobes (P = 0.0288). Conclusions: We identified relationships between the location of a primary tumor and specific nodal upstaging in patients with clinical stage I NSCLC who undergo lobectomy. We found the following: 1) only 1 patient had a positive level eight or nine lymph node out of 645 patients; 2) only LUL primary tumors demonstrated upstaging to level five or six lymph nodes; and 3) right upper lobe tumors were significantly less likely to be associated with a positive level 12 lymph node. <feminine ordinal indicator> 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:578 / 584
页数:7
相关论文
共 50 条
  • [1] Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer
    Li, Minghuan
    Liu, Ningbo
    Hu, Man
    Shi, Fang
    Yuan, Shuanghu
    Zhang, Pinliang
    Fu, Zheng
    Yang, Guoren
    Yu, Jinming
    LUNG CANCER, 2009, 63 (03) : 383 - 386
  • [2] Skip mediastinal nodal metastases in non-small cell lung cancer
    Tanaka, F
    Takenaka, K
    Oyanagi, H
    Fujinaga, T
    Otake, Y
    Yanagihara, K
    Ito, H
    Wada, H
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (06) : 1114 - 1120
  • [3] Relationship between prognosis and nodal micrometastasis in patients with non-small cell lung cancer
    Kawaguchi, Koji
    Yatabe, Yasushi
    Yokoi, Kohei
    Mitsudomi, Tetsuya
    CHEST, 2006, 130 (04) : 232S - 232S
  • [4] Nodal metastases in non-small cell lung cancer: Hop, skip, or jump?
    Rusch, Valerie W.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2015, 150 (04): : 765 - 766
  • [5] GENOMIC HETEROGENEITY BETWEEN PRIMARY NON-SMALL CELL LUNG CANCER AND ITS METASTASES
    Zhong, Wen-Zhao
    Chen, Zhi-Yong
    Zhang, Xu-Chao
    Su, Jian
    Yang, Xue-Ning
    Chen, Zhi-Hong
    Yang, Jin-Ji
    Zhou, Qing
    Chen, Hua-Jun
    Mok, Tony
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S388 - S389
  • [6] INCIDENCE OF BRAIN METASTASES AT DIAGNOSIS IN OTHERWISE STAGE I NON-SMALL CELL LUNG CANCER
    Farne, H. A.
    Banks, T.
    Bloch, S. A.
    Ross, C. L.
    THORAX, 2019, 74 : A132 - A132
  • [7] Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases
    Yoshino, I
    Nakanishi, R
    Osaki, T
    Takenoyama, M
    Taga, S
    Hanagiri, T
    Yasumoto, K
    CHEST, 1999, 116 (01) : 144 - 149
  • [8] Nodal Involvement Pattern in Clinical Stage IA Non-Small Cell Lung Cancer According to Tumor Location
    Meng, Shushi
    Liu, Ganwei
    Wang, Shaodong
    Yang, Fan
    Wang, Jun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7875 - 7880
  • [9] Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease
    Farrell, MA
    McAdams, HP
    Herndon, JE
    Patz, EF
    RADIOLOGY, 2000, 215 (03) : 886 - 890
  • [10] Comparison of MET Expression in Primary and Corresponding Nodal and Distant Metastases in Non-Small Cell Lung Cancer (NSCLC)
    Tamjid, Babak
    Mitchell, Paul
    John, Thomas
    Knight, Simon
    Morey, Adrienne
    Murone, Carmel
    Asadi, Khashayar
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S471 - S471